| 摘要 |
<p>The present invention provides a compound of formula (I), and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a diseease or condition mediated by CDK9.</p> |
| 申请人 |
NOVARTIS AG;BARSANTI, PAUL, A.;HU, CHENG;JIN, JEFF;KEYES, ROBERT;KUCEJKO, ROBERT;LIN, XIAODONG;PAN, YUE;PFISTER, KEITH, B.;SENDZIK, MARTIN;SUTTON, JAMES;WAN, LIFENG |
发明人 |
BARSANTI, PAUL, A.;HU, CHENG;JIN, JEFF;KEYES, ROBERT;KUCEJKO, ROBERT;LIN, XIAODONG;PAN, YUE;PFISTER, KEITH, B.;SENDZIK, MARTIN;SUTTON, JAMES;WAN, LIFENG |
